Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
News > Business News
Audio By Carbonatix
4:01 PM on Monday, November 3
The Associated Press
DALLAS--(BUSINESS WIRE)--Nov 3, 2025--
Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, will be presenting at 3 upcoming healthcare conferences.
Forte will be presenting at the Guggenheim 2 nd Annual Healthcare Innovation Conference at the InterContinental Boston in Boston MA on Mon, Nov 10 at 3:30-3:55 PM ET.
On Nov. 12 at 2:00-2:20 PM ET, Forte will present at the virtual TD Cowen Immunology and Inflammation Summit.
Additionally on Dec 4 at 11:15-11:35 AM ET, Forte will be presenting at the 8 th Annual Evercore Healthcare Conference in Coral Gables FL at the Loews Hotel.
Source: Forte Biosciences, Inc.
View source version on businesswire.com:https://www.businesswire.com/news/home/20251103872383/en/
CONTACT: LifeSci Advisors
Mike Moyer, Managing Director
[email protected] Biosciences, Inc.
Paul Wagner, CEO
KEYWORD: UNITED STATES NORTH AMERICA TEXAS
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Forte Biosciences, Inc.
Copyright Business Wire 2025.
PUB: 11/03/2025 04:01 PM/DISC: 11/03/2025 04:01 PM
http://www.businesswire.com/news/home/20251103872383/en
